Professor Yona Keisari
Chief Scientific Officer
Alpha Tau Medical LTD, Tel Aviv, Israel
Department of Clinical Microbiology and Immunology
Sackler Faculty of Medicine, Tel Aviv University, Israel
Member of the Dept. of Clinical Microbiology and Immunology, Faculty of Medicine, Tel Aviv University, Israel, since 1979. Full Professor (2002-2015), Prof. Emeritus since 2015.
Chief Scientific Officer and co-founder of Alpha Tau Medical, Tel Aviv Israel since 2016. Responsible for promoting and organizing clinical trials worldwide and for basic and translational research.
Main research topics:
I. Development of tumor destruction (ablation) treatments of solid metastatic tumors by a unique intratumoral alpha radiation treatment using radium-224 loaded sources (Diffusing alpha-emitters radiation therapy, DaRT).
II. The activation of anti-tumoral immune reactivity by in situ destruction of solid tumors with DaRT and developing immuno-manipulating means to augment such immune responses and achieve improved eradication of metastases.
Co-author of 92 peer reviewed scientific papers, 6 reviews, 5 chapters in books, edited 2 books, and two patents. Deputy editor of “mediators of inflammation” and member of editorial board of 5 other journals. Supervised 17 Ph.D. students and 36 M.Sc. students.
One of the founders and past president of the “Israeli Society for Cancer Research” (ISCR). Since 2015 serve as the treasurer of the “International Cancer Microenvironment Society”. Held a variety of management positions at the Tel Aviv University, and in national and international professional societies, and served as a member of the executive committee of the “European Association for Cancer Research (EACR)” (2013-2015).